Literature DB >> 469370

The measurement of erythrocyte deformability using micropore membranes. A sensitive technique with clinical applications.

P F Leblond, L Coulombe.   

Abstract

This article describes a positive-pressure filtration technique using low pore-density, 3 microns pore-diameter polycarbonate membranes employed to evaluate erythrocyte deformability in a clinically oriented hematology laboratory. Mean erythrocyte resistance to filtration was expressed by a numerical index which takes into account both the initial resistance of dilute red cell suspensions to passage across the membrane and the relative pressure rise observed after filtration of 30 ml of the same suspension (3 . 10(8) cells). The resistance index of 99 blood samples obtained from 88 healthy adult volunteers ranged between 1.4 and 2.9, with normal Gaussian distribution and mean of 2.04. Values obtained on similarly prepared samples from 20 patients with various hemolytic anemias always fell outside this range, indicating a reduced deformability in every case. The existence of a strong positive correlation was found between the resistance index and the degree of reticulocytosis in these patients. This method appears more sensitive than previously described filtration techniques in detecting the presence of small numbers of poorly deformable erythrocytes in vivo, while being more practical and statistically more significant than the micropipette elastimetry technique. Our results, however, raise a new question concerning the role of reticulocytes in the evaluation of red cell deformability on blood samples from patients with hemolytic anemia.

Entities:  

Mesh:

Year:  1979        PMID: 469370

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Insulin-driven erythropoiesis may underlie impairment of erythrocyte deformability in hyperinsulinaemic, hyperglycaemic ob/ob-mice.

Authors:  K G Engström; K Grankvist; I B Täljedal
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

Review 2.  Erythrocyte rheology.

Authors:  J Stuart
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

3.  Analysis of factors regulating erythrocyte deformability.

Authors:  N Mohandas; M R Clark; M S Jacobs; S B Shohet
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

4.  A new method to study shape recovery of red blood cells using multiple optical trapping.

Authors:  P J Bronkhorst; G J Streekstra; J Grimbergen; E J Nijhof; J J Sixma; G J Brakenhoff
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

5.  Heterogeneity in filterability of erythrocytes from malaria (Plasmodium berghei)-infected blood.

Authors:  S Pattanakitsakul; Y Yuthavong
Journal:  Experientia       Date:  1982-05-15

6.  Effect of catecholamines on deformability of red cells from trout: relative roles of cyclic AMP and cell volume.

Authors:  G Chiocchia; R Motais
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

7.  Band 3 antagonists, p-azidobenzylphlorizin and DIDS, mediate erythrocyte shape and flexibility changes as characterized by digital image morphometry and microfiltration.

Authors:  D M Hoefner; M E Blank; B M Davis; D F Diedrich
Journal:  J Membr Biol       Date:  1994-07       Impact factor: 1.843

8.  Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics.

Authors:  D K Kaul; M E Fabry; P Windisch; S Baez; R L Nagel
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial.

Authors:  J J Belch; J Cormie; P Newman; M McLaren; J Barbenel; H Capell; P Leiberman; C D Forbes; C R Prentice
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

10.  Decreased membrane deformability in Melanesian ovalocytes from Papua New Guinea.

Authors:  A Saul; G Lamont; W H Sawyer; C Kidson
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.